Somatics, LLC is a world leader in ECT (Electroconvulsive Therapy) innovation and sales, offering the FDA-cleared Thymatron device for the treatment of severe depression and catatonia in patients aged 13 years and older.
The Thymatron instrument stands out for its positive safety profile, incorporating multiple levels of error protection and efficient operation, while its proprietary computer methods ensure optimal stimulus delivery, seizure quality analysis, and seizure endpoint determination, providing a concise end-of-treatment report.
Generated from the website